Observe Medical secures first significant UnoMeter[(TM)] Safeti[(TM)] Plus orders across multiple key countries

25 Nov 2024 15:53 CET

Oslo, November 25[th], 2024 - Only 1 week after launching UnoMeter[(TM)]
Safeti[(TM)] Plus at MEDICA trade fair, Observe Medical ("the Company" or
"Observe Medical") has received orders from Spain, Germany, Austria, Nordics,
Switzerland, Baltics, Croatia and UAE with a total net sales value of NOK 3.5
million.

The initial orders from these countries represent a market potential of NOK 95
million in annual recurring revenue, based on the historical sales performance
of UnoMeter[(TM)] Safeti[(TM)] Plus. This corresponds to 45% of the product's
total historic annual revenue.

These orders mark a significant milestone for the Company, advancing its goal of
capitalizing on the UnoMeter[(TM) ]Portfolio's market potential. Additionally,
they lay the groundwork for future growth by establishing a robust distribution
platform, supporting upcoming product launches, not least our strategically
important digital solution, UnoMeter[(TM)] Sippi.

Jørgen Mann, CEO of Observe Medical, commented, "The fact that we only 1 week
after the launch of UnoMeter[(TM)] Safeti[(TM)] Plus at MEDICA trade fair have
orders from several major countries that combined have a significant value, is a
confirmation of our expectation, that there is a clear market need for our
solutions. It is our impression that no other products have been able to step
into the space that was made vacant when UnoMeters[(TM)] left the market some 2
years ago. The orders vary in size, but they all represent the distributors
ambitions to take back the historic market share of the UnoMeter[(TM)]
products".

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.

More information:
Access the news on Oslo Bors NewsWeb site

633115_Observe_Medical_secures_first_significant_UnoMeter_TM_Safeti_TM_Plus_orders_across_multiple_key_countries.pdf